血流通过依赖于连接体的Alk1活性来调节转录
Anthony R Anzell1,2, Amy Biery Kunz1,3, James P Donovan1,4
1Department of Human Genetics, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
通过了解血流和BMP10如何调节ACVRL1的表达,遗传性出血端膜炎 (HHT) 的治疗可能会得到改善. 增强ACVRL1可以通过增加信号和表达来提供针对HHT的向治疗.
科学领域:
- 血管生物学 血管生物学
- 遗传学 是一个遗传学.
- 分子医学是分子医学.
背景情况:
- 遗传性出血端膜炎症 (HHT) 是一种自体主导性疾病,由于ACVRL1/ALK1或ENG的突变,导致动脉静脉形 (AVM).
- 增强ACVRL1表达是HTT的潜在治疗策略,需要了解其调节.
结论:
- BMP10在血流下游作用,通过积极反机制维持ACVRL1的表达.
- 激活ALK1的向疗法可以通过增加ALK1信号和ACVRL1表达来增加HHT治疗的双重效益.
更多相关视频
07:12Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
09:20The Assembly and Application of 'Shear Rings': A Novel Endothelial Model for Orbital, Unidirectional and Periodic Fluid Flow and Shear Stress
Published on: October 31, 2016
相关概念视频
Regulation of Angiogenesis and Blood Supply
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Allosteric Regulation
Blood Flow
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Intracellular Signaling Affects Focal Adhesions
Some...
